Cardiovascular function in a chronic peritoneal dialysis pediatric population on recombinant human erythropoietin treatment

S. Bassi, G. Montini, A. Edefonti, F. Perfumo, D. Cattarelli, G. Piaggio, V. Fesslova, G. Zacchello, S. Bove

Research output: Contribution to journalArticle

Abstract

Anemia, through a hyperkinetic state, is an important contributor to myocardial function impairment. To determine the cardiovascular effects of recombinant human erythropoietin (rHuEPO) therapy, 10 chronic peritoneal dialysis (CPD)-treated anemic children were studied before and during 18 months of treatment. The following parameters were recorded: hemoglobin (Hb) [percent of target level (TL) = x-2 standard deviations of normal Hb values for age and sex], heart rate (HR, beats/minute), mean arterial pressure (MAP, mmHg), end diastolic left ventricular diameter (EDLVD, mm/sm BSA), shortening fraction (SF, percent), and interventricular septal thickness (IVS, mm/sm BSA). Student's t-test for paired data showed (vs time before treatment, TO) a progressive increase in Hb, a progressive decrease in HR, and a progressive increase in MAP. EDLVD progressively decreased, while SF and IVS remained unchanged throughout the study. Regression analysis showed a close correlation between anemia correction and decrease of HR (p

Original languageEnglish
JournalPeritoneal Dialysis International
Volume13
Issue numberSUPPL. 2
Publication statusPublished - 1993

Fingerprint

Peritoneal Dialysis
Erythropoietin
Hemoglobins
Pediatrics
Anemia
Population
Arterial Pressure
Reference Values
Therapeutics
Heart Rate
Regression Analysis
Students

Keywords

  • Chronic anemia
  • Chronic peritoneal dialysis
  • Chronic renal failure
  • Echocardiography
  • Myocardial function
  • Recombinant human erythropoietin

ASJC Scopus subject areas

  • Nephrology

Cite this

Cardiovascular function in a chronic peritoneal dialysis pediatric population on recombinant human erythropoietin treatment. / Bassi, S.; Montini, G.; Edefonti, A.; Perfumo, F.; Cattarelli, D.; Piaggio, G.; Fesslova, V.; Zacchello, G.; Bove, S.

In: Peritoneal Dialysis International, Vol. 13, No. SUPPL. 2, 1993.

Research output: Contribution to journalArticle

@article{4d8e7d55de074bbd8a93dd19211c1705,
title = "Cardiovascular function in a chronic peritoneal dialysis pediatric population on recombinant human erythropoietin treatment",
abstract = "Anemia, through a hyperkinetic state, is an important contributor to myocardial function impairment. To determine the cardiovascular effects of recombinant human erythropoietin (rHuEPO) therapy, 10 chronic peritoneal dialysis (CPD)-treated anemic children were studied before and during 18 months of treatment. The following parameters were recorded: hemoglobin (Hb) [percent of target level (TL) = x-2 standard deviations of normal Hb values for age and sex], heart rate (HR, beats/minute), mean arterial pressure (MAP, mmHg), end diastolic left ventricular diameter (EDLVD, mm/sm BSA), shortening fraction (SF, percent), and interventricular septal thickness (IVS, mm/sm BSA). Student's t-test for paired data showed (vs time before treatment, TO) a progressive increase in Hb, a progressive decrease in HR, and a progressive increase in MAP. EDLVD progressively decreased, while SF and IVS remained unchanged throughout the study. Regression analysis showed a close correlation between anemia correction and decrease of HR (p",
keywords = "Chronic anemia, Chronic peritoneal dialysis, Chronic renal failure, Echocardiography, Myocardial function, Recombinant human erythropoietin",
author = "S. Bassi and G. Montini and A. Edefonti and F. Perfumo and D. Cattarelli and G. Piaggio and V. Fesslova and G. Zacchello and S. Bove",
year = "1993",
language = "English",
volume = "13",
journal = "Peritoneal Dialysis International",
issn = "0896-8608",
publisher = "Multimed Inc.",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Cardiovascular function in a chronic peritoneal dialysis pediatric population on recombinant human erythropoietin treatment

AU - Bassi, S.

AU - Montini, G.

AU - Edefonti, A.

AU - Perfumo, F.

AU - Cattarelli, D.

AU - Piaggio, G.

AU - Fesslova, V.

AU - Zacchello, G.

AU - Bove, S.

PY - 1993

Y1 - 1993

N2 - Anemia, through a hyperkinetic state, is an important contributor to myocardial function impairment. To determine the cardiovascular effects of recombinant human erythropoietin (rHuEPO) therapy, 10 chronic peritoneal dialysis (CPD)-treated anemic children were studied before and during 18 months of treatment. The following parameters were recorded: hemoglobin (Hb) [percent of target level (TL) = x-2 standard deviations of normal Hb values for age and sex], heart rate (HR, beats/minute), mean arterial pressure (MAP, mmHg), end diastolic left ventricular diameter (EDLVD, mm/sm BSA), shortening fraction (SF, percent), and interventricular septal thickness (IVS, mm/sm BSA). Student's t-test for paired data showed (vs time before treatment, TO) a progressive increase in Hb, a progressive decrease in HR, and a progressive increase in MAP. EDLVD progressively decreased, while SF and IVS remained unchanged throughout the study. Regression analysis showed a close correlation between anemia correction and decrease of HR (p

AB - Anemia, through a hyperkinetic state, is an important contributor to myocardial function impairment. To determine the cardiovascular effects of recombinant human erythropoietin (rHuEPO) therapy, 10 chronic peritoneal dialysis (CPD)-treated anemic children were studied before and during 18 months of treatment. The following parameters were recorded: hemoglobin (Hb) [percent of target level (TL) = x-2 standard deviations of normal Hb values for age and sex], heart rate (HR, beats/minute), mean arterial pressure (MAP, mmHg), end diastolic left ventricular diameter (EDLVD, mm/sm BSA), shortening fraction (SF, percent), and interventricular septal thickness (IVS, mm/sm BSA). Student's t-test for paired data showed (vs time before treatment, TO) a progressive increase in Hb, a progressive decrease in HR, and a progressive increase in MAP. EDLVD progressively decreased, while SF and IVS remained unchanged throughout the study. Regression analysis showed a close correlation between anemia correction and decrease of HR (p

KW - Chronic anemia

KW - Chronic peritoneal dialysis

KW - Chronic renal failure

KW - Echocardiography

KW - Myocardial function

KW - Recombinant human erythropoietin

UR - http://www.scopus.com/inward/record.url?scp=0027240430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027240430&partnerID=8YFLogxK

M3 - Article

C2 - 8399585

AN - SCOPUS:0027240430

VL - 13

JO - Peritoneal Dialysis International

JF - Peritoneal Dialysis International

SN - 0896-8608

IS - SUPPL. 2

ER -